SciELO - Scientific Electronic Library Online

 
vol.58 issue3Bibliometric Study About the Impact of Biosimilars Drugs author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Ars Pharmaceutica (Internet)

On-line version ISSN 2340-9894

Abstract

RESTREPO-ESPINOSA, Diana C. et al. Anticoagulant properties of a high molecular weight polysaccharide fraction (1000RS) of the ascidian Microcosmus exasperatus. Ars Pharm [online]. 2017, vol.58, n.3, pp.95-101.  Epub Dec 12, 2022. ISSN 2340-9894.  https://dx.doi.org/10.30827/ars.v58i3.6526.

Aims:

The anticoagulant effect and cytotoxicity of a high molecular weight polysaccharide fraction (1000RS) obtained from the tunic of the ascidia Microcosmus exasperatus were evaluated.

Methods:

Anticoagulant properties of 1000RS was evaluated by activated Partial Thromboplastin Time (aPTT), Thrombin Time (TT), Prothrombin Time (PT), anti-factor Xa and lupic anticoagulant (dRVVT) assays. Cytotoxicity was tested on murine hematopoietic cells using MTT assay.

Results:

This galactose rich fraction showed to be a potential anticoagulant due to its inhibitory effect on the intrinsic coagulation pathway. At the same time, anticoagulant doses of this fraction have no effect on cellular viability, which means that it can be used as a therapeutic agent.

Conclusion:

In vitro anticoagulant effect of 1000RS occurs at innocuous doses, however, it still need to be tested using in vivo models and its cytotoxicity evaluated in normal human cell lines.

Keywords : anticoagulants; ascidian; Microcosmus exasperatus; polysaccharides.

        · abstract in Spanish     · text in English     · English ( pdf )